Venturing into ventricular arrhythmia storm: A systematic review and meta-analysis

European Heart Journal

Volumn 34, Issue 8, 2013, Pages

  Nayyar, Sachin ^a   Ganesan, Anand N ^a   Brooks, Anthony G ^a   Sullivan, Thomas ^a   Roberts Thomson, Kurt C ^a   Sanders, Prashanthan ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Ablation; Storm; Ventricular fibrillation; Ventricular tachycardia

Indexed keywords

ABLATION THERAPY; CARDIOMYOPATHY; CATHETER ABLATION; CLINICAL EFFECTIVENESS; FOLLOW UP; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA STORM; HEART VENTRICLE FIBRILLATION; HUMAN; MONOMORPHIC VENTRICULAR TACHYCARDIA; MORTALITY; PATIENT SAFETY; POLYMORPHIC VENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; CATHETER ABLATION; HUMANS; MIDDLE AGED; RECURRENCE; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 84874461948     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs453     Document Type: Review

References (79)

1. Aliot EM, Stevenson WG, Almendral-Garrote JM, Bogun F, Calkins CH, Delacretaz E, Della Bella P, Hindricks G, Jais P, Josephson ME, Kautzner J, Kay GN, Kuck KH, Lerman BB, Marchlinski F, Reddy V, Schalij MJ, Schilling R, Soejima K, Wilber D. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Heart Rhythm 2009;6:886-933.
2. Exner DV, Pinski SL, Wyse DG, Renfroe EG, Follmann D, Gold M, Beckman KJ, Coromilas J, Lancaster S, Hallstrom AP. Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation 2001;103:2066-2071.
3. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006;48: e247-e346.
4. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
5. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237.
6. Myerburg RJ, Castellanos A. Clinical trials of implantable defibrillators. N Engl J Med 1997;337:1621-1623.
7. Sesselberg HW, Moss AJ, McNitt S, Zareba W, Daubert JP, Andrews ML, Hall WJ, McClinitic B, Huang DT. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II sub-study. Heart Rhythm 2007;4:1395-1402.
8. Verma A, Kilicaslan F, Marrouche NF, Minor S, Khan M, Wazni O, Burkhardt JD, Belden WA, Cummings JE, Abdul-Karim A, Saliba W, Schweikert RA, Tchou PJ, Martin DO, Natale A. Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm. J Cardiovas Electrophysiol 2004;15:1265-1270.
9. Gatzoulis KA, Andrikopoulos GK, Apostolopoulos T, Sotiropoulos E, Zervopoulos G, Antoniou J, Brili S, Stefanadis CI. Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy. Europace 2005;7:184-192.
10. Larsen GK, Evans J, Lambert WE, Chen Y, Raitt MH. Shocks burden and increased mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 2011;8: 1881-1886.
11. Shepard RK, Ellenbogen KA. Predicting outcome after implantable cardioverter-defibrillator therapy: a new piece to the puzzle? J Am Coll Cardiol 2009;54: 829-831.
12. Frankel DS, Mountantonakis SE, Robinson MR, Zado ES, Callans DJ, Marchlinski FE. Ventricular tachycardia ablation remains treatment of last resort in structural heart disease: argument for earlier intervention. J Cardiovasc Electro-physiol 2011;22:1123-1128.
13. Tokuda M, Sobieszczyk P, Eisenhauer AC, Kojodjojo P, Inada K, Koplan BA, Michaud GF, John RM, Epstein LM, Sacher F, Stevenson WG, Tedrow UB. Trans-coronary ethanol ablation for recurrent ventricular tachycardia after failed catheter ablation: an update. Circ Arrhythm Electrophysiol 2011;4:889-896.
14. Stevenson WG, Wilber DJ, Natale A, Jackman WM, Marchlinski FE, Talbert T, Gonzalez MD, Worley SJ, Daoud EG, Hwang C, Schuger C, Bump TE, Jazayeri M, Tomassoni GF, Kopelman HA, Soejima K, Nakagawa H. Irrigated radio-frequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation 2008;118:2773-2782.
15. Tanner H, Hindricks G, Volkmer M, Furniss S, Kuhlkamp V, Lacroix D, C DEC, Almendral J, Caponi D, Kuck KH, Kottkamp H. Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-study. J Cardiovasc Electrophysiol 2010;21:47-53.
16. Centre for Reviews and Dissemination. Undertaking systematic reviews of research on effectiveness: CRD's guidance for carrying out or commissioning reviews. In: Khan KS, Riet Gt, Glanville J, Sowden AJ, Kleijnen J eds. Undertaking Systematic Reviews of Research on Effectiveness. 2nd ed. York: NHS Centre for Reviews and Dissemination, University of York; 2001.
17. Montijano Cabrera nM, Barrera Cordero A, Alzueta RodrIguez J, Robledo Carmona J, de Teresa Galv n E. Radiofrequency catheter ablation of ventricular tachycardia in patients with an implantable defibrillator. Long-term follow-up. Revista Espanola de Cardiologia 2005;58:491-498.
18. Kozluk E, Gaj S, Kiliszek M, Lodzinski P, Piatkowska A, Opolski G. Efficacy of catheter ablation in patients with an electrical storm. Kardiol Pol 2011;69:665-670.
19. Trappe HJ, Klein H, Wenzlaff P, Lichtlen PR. Significance of catheter ablation as emergency intervention in patients with sustained monomorphic ventricular tachycardia. Z Kardiol 1991;80:720-726.
20. Sosa E, Scanavacca M, d'Avila A, Oliveira F, Ramires JA. Nonsurgical transthoracic epicardial catheter ablation to treat recurrent ventricular tachycardia occurring late after myocardial infarction. J Am Coll Cardiol 2000;35:1442-1449.
21. O'Callaghan PA, Poloniecki J, Sosa-Suarez G, Ruskin JN, McGovern BA, Garan H. Long-term clinical outcome of patients with prior myocardial infarction after palliative radiofrequency catheter ablation for frequent ventricular tachycardia. Am J Cardiol 2001;87:975-979.
22. Fiala M, Chovanzik J, Neuwirth R, Nykl I, Szymeczek H, Nevralova R, Jiravsky O, Branny M. Sustained monomorphic ventricular tachycardia in patients with structural heart disease. Different arrhythmogenic substrates, different options of palliative and curative treatment in the era of three-dimensional mapping. Vnitr Lek 2006;52:577-589.
23. Volkmer M, Ouyang F, Deger F, Ernst S, Goya M, Bansch D, Berodt K, Kuck KH, Antz M. Substrate mapping vs. tachycardia mapping using CARTO in patients with coronary artery disease and ventricular tachycardia: impact on outcome of catheter ablation. Europace 2006;8:968-976.
24. Eckart RE, Hruczkowski TW, Tedrow UB, Koplan BA, Epstein LM, Stevenson WG. Sustained ventricular tachycardia associated with corrective valve surgery. Circulation 2007;116:2005-2011.
25. Grimard C, Lacotte J, Hidden-Lucet F, Duthoit G, Gallais Y, Frank R. Percutaneous epicardial radiofrequency ablation of ventricular arrhythmias after failure of endocardial approach: a 9-year experience. J Cardiovasc Electrophysiol 2010; 21:56-61.
26. Della Bella P, Brugada J, Zeppenfeld K, Merino J, Neuzil P, Maury P, Maccabelli G, Vergara P, Baratto F, Berruezo A, Wijnmaalen AP. Epicardial ablation for ventricular tachycardia: a European multicenter study. Circ Arrhythm Electrophysiol 2011;4: 653-659.
27. Russo AD, Casella M, Pieroni M, Pelargonio G, Bartoletti S, Santangeli P, Zucchetti M, Innocenti E, Di Biase L, Carbucicchio C, Bellocci F, Fiorentini C, Natale A, Tondo C. Drug-refractory ventricular tachycardias after myocarditis /clinical perspective. Circ Arrhythm Electrophysiol 2012;5:492-498.
28. Nellens P, Gursoy S, Andries E, Brugada P. Transcoronary chemical ablation of arrhythmias. Pacing Clin Electrophysiol 1992;15:1368-1373.
29. Morady F, Harvey M, Kalbfleisch SJ, el-Atassi R, Calkins H, Langberg JJ. Radiofre-quency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation 1993;87:363-372.
30. Ometto R, Bedogni F, La Vecchia L, Finocchi G, Mosele GM, Vincenzi M. Radio-frequency catheter ablation of the slow reentrant pathway of sustained ventricular tachycardia. Pacing Clin Electrophysiol 1993;16:1898-1905.
31. Willems S, Borggrefe M, Shenasa M, Chen X, Hindricks G, Haverkamp W, Wietholt D, Block M, Breithardt G. Radiofrequency catheter ablation of ventricular tachycardia following implantation of an automatic cardioverter defibrillator. Pacing Clin Electrophysiol 1993;16:1684-1692.
32. Kottkamp H, Hindricks G, Chen X, Brunn J, Willems S, Haverkamp W, Block M, Breithardt G, Borggrefe M. Radiofrequency catheter ablation of sustained ventricular-tachycardia in idiopathic dilated cardiomyopathy. Circulation 1995;92: 1159-1168.
33. Cao K, Gonska BD. Catheter ablation of incessant ventricular tachycardia: acute and long-term results. Eur Heart J 1996;17:756-763.
34. Sato M, Sakurai M, Yotsukura A, Betsuyaku T, Ito T, Yoshida I, Kitabatake A. The efficacy of radiofrequency catheter ablation for the treatment of ventricular tachycardia associated with cardiomyopathy. Jpn Circ J 1997;61:55-63.
35. Haissaguerre M, Shoda M, Jais P, Nogami A, Shah DC, Kautzner J, Arentz T, Kalushe D, Lamaison D, Griffith M, Cruz F, de Paola A, Gaita F, Hocini M, Garrigue S, Macle L, Weerasooriya R, Clementy J. Mapping and ablation of idio-pathic ventricular fibrillation. Circulation 2002;106:962-967.
36. Haissaguerre M, Extramiana F, Hocini M, Cauchemez B, Jais P, Cabrera JA, Farre J, Leenhardt A, Sanders P, Scavee C, Hsu LF, Weerasooriya R, Shah DC, Frank R, Maury P, Delay M, Garrigue S, Clementy J. Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes. Circulation 2003; 108:925-928.
37. Bansch D, Oyang F, Antz M, Arentz T, Weber R, Val-Mejias JE, Ernst S, Kuck KH. Successful catheter ablation of electrical storm after myocardial infarction. Circulation 2003;108:3011-3016.
38. Brugada J, Berruezo A, Cuesta A, Osca J, Chueca E, Fosch X, Wayar L, Mont L. Nonsurgical transthoracic epicardial radiofrequency ablation: An alternative in incessant ventricular tachycardia. J Am Coll Cardiol 2003;41:2036-2043.
39. Kottkamp H, Wetzel U, Schirdewahn P, Dorszewski A, Gerds-Li JH, Carbucicchio C, Kobza R, Hindricks G. Catheter ablation of ventricular tachycardia in remote myocardial infarction: substrate description guiding placement of individual linear lesions targeting noninducibility. J Cardiovasc Electrophysiol 2003;14: 675-681.
40. Silva RM, Mont L, Nava S, Rojel U, Matas M, Brugada J. Radiofrequency catheter ablation for arrhythmic storm in patients with an implantable cardioverter defib-rillator. Pacing Clin Electrophysiol 2004;27:971-975.
41. Marrouche NF, Verma A, Wazni O, Schweikert RA, Martin DO, Saliba W, Kilicaslan F, Cummings JE, Burkhardt DJ, Bhargava M, Bash D, Brachmann J, Guenther J, Hao S, Beheiry S, Rossillo A, Raviele A, Themistoclakis S, Natale A. Mode of Initiation and Ablation of Ventricular Fibrillation Storms In Patients With Ischemic Cardiomyopathy. JACC 2004;43:1715-1720.
42. Szumowski L, Sanders P, Walczak F, Hocini M, Jais P, Kepski R, Szufladowicz E, Urbanek P, Derejko P, Bodalski R, Haissaguerre M. Mapping and ablation of polymorphic ventricular tachycardia after myocardial infarction. J Am Coll Cardiol 2004; 44:1700-1706.
43. Schreieck J, Zrenner B, Deisenhofer I, Schmitt C. Rescue ablation of electrical storm in patients with ischemic cardiomyopathy: a potential-guided ablation approach by modifying substrate of intractable, unmappable ventricular tachycardias. Heart Rhythm 2005;2:10-14.
44. Mlcochova H, Saliba WI, Burkhardt DJ, Rodriguez RE, Cummings JE, Lakkireddy D, Patel D, Natale A. Catheter ablation of ventricular fibrillation storm in patients with infiltrative amyloidosis of the heart. J Cardiovasc Electrophy-siol 2006;17:426-430.
45. Dandamudi G, Ghumman WS, Das MK, Miller JM. Endocardial catheter ablation of ventricular tachycardia in patients with ventricular assist devices. Heart Rhythm 2007;4:1165-1169.
46. Reithmann C, Hahnefeld A, Oversohl N, Ulbrich M, Remp T, Steinbeck G. Reinitiation of ventricular macroreentry within the His-Purkinje system by back-up ventricular pacing: a mechanism of ventricular tachycardia storm. Pacing Clin Elec-trophysiol 2007;30:225-235.
47. Bode K, Hindricks G, Piorkowski C, Sommer P, Janousek J, Dagres N, Arya A. Ablation of polymorphic ventricular tachycardias in patients with structural heart disease. Pacing Clin Electrophysiol 2008;31:1585-1591.
48. Carbucicchio C, Santamaria M, Trevisi N, Maccabelli G, Giraldi F, Fassini G, Riva S, Moltrasio M, Cireddu M, Veglia F, Della Bella P. Catheter ablation for the treatment of electrical storm in patients with Implantable cardioverter-defibrillators: short-and long-term outcomes in a prospective single-center study. Circulation 2008;117:462-469.
49. Nayak HM, Verdino RJ, Russo AM, Gerstenfeld EP, Hsia HH, Lin D, Dixit S, Cooper JM, Callans DJ, Marchlinski FE. Ventricular tachycardia storm after initiation of biventricular pacing: incidence, clinical characteristics, management, and outcome. J Cardiovasc Electrophysiol 2008;19:708-715.
50. Sakata T, Tanner H, Stuber T, Delacretaz E. His-Purkinje system re-entry in patients with clustering ventricular tachycardia episodes. Europace 2008;10: 289-293.
51. Uusimaa P, Ylitalo K, Anttonen O, Kerola T, Virtanen V, Paakko E, Raatikainen P. Ventricular tachyarrhythmia as a primary presentation of sarcoidosis. Europace 2008;10:760-766.
52. Enjoji Y, Mizobuchi M, Muranishi H, Miyamoto C, Utsunomiya M, Funatsu A, Kobayashi T, Nakamura S. Catheter ablation of fatal ventricular tachyarrhythmias storm in acute coronary syndrome-role of Purkinje fiber network. J Interv Cardiac Electrophysiol 2009;26:207-215.
53. Haghjoo M, Hindricks G, Bode K, Piorkowski C, Bollmann A, Arya A. Initial clinical experience with the new irrigated tip magnetic catheter for ablation of scar-related sustained ventricular tachycardia: a small case series. J Cardiovasc Electro-physiol 2009;20:935-939.
54. Sinha AM, Schmidt M, Marschang H, Gutleben K, Ritscher G, Brachmann J, Marrouche NF. Role of left ventricular scar and Purkinje-like potentials during mapping and ablation of ventricular fibrillation in dilated cardiomyopathy. Pacing Clin Electrophysiol 2009;32:286-290.
55. Arya A, Bode K, Piorkowski C, Bollmann A, Sommer P, Gaspar T, Wetzel U, Husser D, Kottkamp H, Hindricks G. Catheter ablation of electrical storm due to monomorphic ventricular tachycardia in patients with nonischemic cardiomy-opathy: acute results and its effect on long-term survival. Pacing Clin Electrophysiol 2010;33:1504-1509.
56. Arya A, Eitel C, Bollmann A, Wetzel U, Sommer P, Gaspar T, Husser D, Piorkowski C, Hindricks G. Catheter ablation of scar-related ventricular tachycardia in patients with electrical storm using remote magnetic catheter navigation. Pacing Clin Electrophysiol 2010;33:1312-1318.
57. Bourke T, Vaseghi M, Michowitz Y, Sankhla V, Shah M, Swapna N, Boyle NG, Mahajan A, Narasimhan C, Lokhandwala Y, Shivkumar K. Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation. Circulation 2010;121:2255-2262.
58. Peichl P, Cihak R, Kozeluhova M, Wichterle D, Vancura V, Kautzner J. Catheter ablation of arrhythmic storm triggered by monomorphic ectopic beats in patients with coronary artery disease. J Interv Card Electrophysiol 2010;27:51-59.
59. Kozeluhova M, Peichl P, Cihak R, Wichterle D, Vancura V, Bytesnik J, Kautzner J. Catheter ablation of electrical storm in patients with structural heart disease. Europace 2011;13:109-113.
60. Deneke T, Shin DI, Lawo T, Bosche L, Balta O, Anders H, Bunz K, Horlitz M, Grewe PH, Lemke B, Mugge A. Catheter ablation of electrical storm in a collaborative hospital network. Am J Cardiol 2011;108:233-239.
61. Ueda A, Fukamizu S, Soejima K, Tejima T, Nishizaki M, Nitta T, Kobayashi Y, Hiraoka M, Sakurada H. Clinical and electrophysiological characteristics in patients with sustained monomorphic reentrant ventricular tachycardia associated with dilated-phase hypertrophic cardiomyopathy. Europace 2012;14: 734-740.
62. Ukena C, Bauer A, Mahfoud F, Schreieck J, Neuberger HR, Eick C, Sobotka PA, Gawaz M, Bohm M. Renal sympathetic denervation for treatment of electrical storm: first-in-man experience. Clin Res Cardiol 2012;101:63-67.
63. Ajijola OA, Lellouche N, Bourke T, Tung R, Ahn S, Mahajan A, Shivkumar K. Bilateral cardiac sympathetic denervation for the management of electrical storm. J Am Coll Cardiol 2012;59:91-92.
64. Trappe HJ, Klein H, Wenzlaff P, Lichtlen PR. The value of catheter ablation as emergency treatment in patients with sustained monomorphic ventricular-tachycardia. Heart 1991;80:720-726.
65. Tikkanen JT, Anttonen O, Junttila MJ, Aro AL, Kerola T, Rissanen HA, Reunanen A, Huikuri HV. Long-term outcome associated with early repolariza-tion on electrocardiography. N Engl J Med 2009;361:2529-2537.
66. Haissaguerre M, Derval N, Sacher F, Jesel L, Deisenhofer I, de Roy L, Pasquie JL, Nogami A, Babuty D, Yli-Mayry S, De Chillou C, Scanu P, Mabo P, Matsuo S, Probst V, Le Scouarnec S, Defaye P, Schlaepfer J, Rostock T, Lacroix D, Lamaison D, Lavergne T, Aizawa Y, Englund A, Anselme F, O'Neill M, Hocini M, Lim KT, Knecht S, Veenhuyzen GD, Bordachar P, Chauvin M, Jais P, Coureau G, Chene G, Klein GJ, Clementy J. Sudden cardiac arrest associated with early repolarization. N Engl J Med 2008;358:2016-2023.
67. Tavernier R, Gevaert S, De Sutter J, De Clercq A, Rottiers H, Jordaens L, Fonteyne W. Long term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhyth-mias. Heart 2001;85:53-56.
68. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NA 3rd, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 2007;298:405-412.
69. Lubitz SA, Goldbarg SH, Mehta D. Sudden cardiac death in infiltrative cardiomy-opathies: sarcoidosis, scleroderma, amyloidosis, hemachromatosis. Prog Cardiovasc Dis 2008;51:58-73.
70. Passman R, Kadish A. Sudden death prevention with implantable devices. Circulation 2007;116:561-571.
71. Mallidi J, Nadkarni GN, Berger RD, Calkins H, Nazarian S. Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease. Heart Rhythm 2011;8:503-510.
72. Littmann L, Rennyson SL. Electrical storm: clinical manifestations and management. Minerva Med 2007;98:489-501.
73. Proietti R, Sagone A. Electrical storm: incidence, prognosis and therapy. Indian Pacing Electrophysiol J 2011;11:34-42.
74. Nakahara S, Tung R, Ramirez RJ, Michowitz Y, Vaseghi M, Buch E, Gima J, Wiener I, Mahajan A, Boyle N, Shivkumar K. Characterization of the arrhythmo-genic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia. J Am Coll Cardiol 2010;55:2355-2365.
75. Bai R, Di Biase L, Shivkumar K, Mohanty P, Tung R, Santangeli P, Saenz LC, Vacca M, Verma A, Khaykin Y, Mohanty S, Burkhardt JD, Hongo R, Beheiry S, Dello Russo A, Casella M, Pelargonio G, Santarelli P, Sanchez J, Tondo C, Natale A. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation. Circ Arrhythm Electrophysiol 2011;4:478-485.
76. Wijnmaalen AP, Schalij MJ, von der Thusen JH, Klautz RJ, Zeppenfeld K. Early reperfusion during acute myocardial infarction affects ventricular tachycardia characteristics and the chronic electroanatomic and histological substrate. Circulation 2010;121:1887-1895.
77. Dosdall DJ, Tabereaux PB, Kim JJ, Walcott GP, Rogers JM, Killingsworth CR, Huang J, Robertson PG, Smith WM, Ideker RE. Chemical ablation of the Pur-kinje system causes early termination and activation rate slowing of long-duration ventricular fibrillation in dogs. Am J Physiol Heart Circ Physiol 2008; 295:H883-H8H9.
78. Khan HH, Maisel WH, Ho C, Suzuki M, Soejima K, Solomon S, Stevenson WG. Effect of radiofrequency catheter ablation of ventricular tachycardia on left ventricular function in patients with prior myocardial infarction. J Interv Card Electro-physiol 2002;7:243-247.
79. Frankel DS, Mountantonakis SE, Zado ES, Anter E, Bala R, Cooper JM, Deo R, Dixit S, Epstein AE, Garcia FC, Gerstenfeld EP, Hutchinson MD, Lin D, Patel VV, Riley MP, Robinson MR, Tzou WS, Verdino RJ, Callans DJ, Marchlinski FE. Noninvasive programmed ventricular stimulation early after ventricular tachycardia ablation to predict risk of late recurrence. J Am Coll Cardiol 2012;59:1529-1535.